Acasă

Center For Health Policies and Studies

COVID-19 показал необходимость в совершенствовании противотуберкулезной помощи, ориентированной на нужды людей

COVID-19 has shown the need to improve people-centered TB care

6/29/2020 11:22 AM
6936
0 Comentarii

COVID-19 demonstrates how vulnerable people with lung diseases can be, and also makes obvious the urgent need to improve quality and strengthened people-centered approaches in TB care delivery.

A quarter of the world‘s population is estimated to be infected with TB bacteria. These people are neither sick nor contagious. However, they are at greater risk of developing TB disease, especially those with weakened immunity. Offering them TB preventive treatment will not only protect them from becoming sick but also cut down on the risk of transmission in the community.

“COVID-19 is highlighting just how vulnerable people with lung diseases and weakened immune systems can be,“ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “The world committed to end TB by 2030; improving prevention is key to making this happen. Millions of people need to be able to take TB preventive treatment to stop the onset of disease, avert suffering and save lives".

Dr Tedros highlighted the importance to continue efforts to tackle longstanding health problems, including TB during global outbreaks such as COVID-19. At the same time, programmes already in place to combat TB and other major infectious diseases can be leveraged to make the response to COVID-19 more effective and rapid.

The overall goal of TB-REP 2.0 is to foster timely TB case detection and improved treatment outcomes in patients with special emphasis on drug-resistant TB, in eleven EECA countries through meaningful involvement of communities and civil society and integrated people-centered TB care delivery systems able to address the needs of key and vulnerable populations.

The program incorporates the full spectrum of DR-TB prevention and care issues, targeting both health and sustainable community systems for improved quality and strengthened people-centered approaches in TB care delivery.

The latest consolidated guidelines recommend a range of innovative approaches to scale up access to TB preventive treatment:

  • WHO recommends a scale-up of TB preventive treatment among populations at highest risk including household contacts of TB patients, people living with HIVand other people at risk with lowered” immunity or living in crowded settings.
  • WHO recommends an integration of TB preventive treatment services into ongoing case finding efforts for active TB. All household contacts of TB patientsand people living with HIV are recommended to be screened for active TB. If active TB is ruled out, they should be initiated on TB preventive treatment. 
  • WHO recommends that either a tuberculin skin test  or interferon-gamma release assay (IGRA) be used to test for TB infection. Both tests are helpful to find people more likely to benefit from TB preventive treatment but should not become a barrier to scale-up access.
  • WHO recommends new shorter options for preventive treatmentin addition to the widely used 6 months of daily isoniazid.

TB preventive treatment is an affordable intervention that can prevent families from sliding into poverty and preserve the health and economy of whole communities. WHO anticipates that as new and safer drugs come onto the markets, and as prices fall, it will become a highly-cost effective way to save millions of lives.


Comments
Add new comment